Immunosuppressive Tumor Microenvironment Signatures Predict Early Progression in NSCLC Patients Receiving Immune Checkpoint Inhibitors: A Transcriptomic and Immune Deconvolution Analysis of GSE135222

<i>Background and Objectives:</i> Early progression (PFS < 90 days) in NSCLC patients undergoing ICI treatment constitutes a significant clinical challenge. Although predictive biomarkers have been extensively investigated, specific transcriptomic and immune microenvironment characteristics contribu...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hilmi Kodaz, Çağnur Elpen Kodaz, Gökhan Öztürk, İsmail Beypınar
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2026-05-01
Edice:	Medicina
Témata:	NSCLC immune checkpoint inhibitors early progression GSEA tumor microenvironment TGF-β
On-line přístup:	https://www.mdpi.com/1648-9144/62/6/1031
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!